Open AccessHelicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea
Author(s) -
Kyu Keun Kang
Publication year - 2014
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v20.i22.6932
Subject(s) - helicobacter pylori , medicine , moxifloxacin , gastroenterology , urea breath test , adverse effect , breath test , concomitant , surgery , helicobacter pylori infection , antibiotics , microbiology and biotechnology , biology
To investigate moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori (H. pylori) infection following failed first-line treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom